Filgrastim Liquid
NDC Package 71861-0001-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Filgrastim liquids is filgrastim is a man-made version of a certain natural substance made in your body. This formulation utilizes a liquid delivery system. Marketed by Hospira Zagreb D.o.o., this product is identified by NDC 71861-0001.

Identification & Billing

NDC Package Code
71861-0001-3
Package Description
1 BOX in 1 PACKAGE / 6 BOTTLE in 1 BOX (71861-0001-2) / 2 kg in 1 BOTTLE (71861-0001-1)
Product Code
71861-0001
11-Digit Billing Format
71861000103

Clinical Specifications

Proprietary Name
Filgrastim
Non-Proprietary Name
Filgrastim
Substance Name
Filgrastim
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s)
FILGRASTIM 1 kg/kg
Usage Information
Filgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, and filgrastim-aafi.

Regulatory & Marketing

Labeler Name
Hospira Zagreb D.o.o.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
10-23-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71861-0001-3 identifies a specific commercial package of 1 box in 1 package / 6 bottle in 1 box (71861-0001-2) / 2 kg in 1 bottle (71861-0001-1) of Filgrastim (UNFINISHED drug), a bulk ingredient labeled by Hospira Zagreb D.o.o.. This liquid is formulated for use and contains filgrastim as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira Zagreb D.o.o. on October 23, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Filgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, and filgrastim-aafi.

How is this Hospira Zagreb D.o.o. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71861000103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71861-0001-3
11-Digit CMS (5-4-2)
71861-0001-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.